A Swedish nationwide study of 227,000 people with alcohol use disorder found that those taking GLP-1 drugs had 36% lower risk of alcohol-related hospitalizations. This is more than double the 14% reduction that the same study found with naltrexone, which was the best-performing medication approved for treatment of alcohol use disorder in that analysis. Other observational studies have linked GLP-1 drugs to lower rates of new and recurring alcohol use disorder, reduced diagnoses and relapse in cannabis use disorder, fewer health care visits for nicotine dependence and lower risk of opioid overdose.
Фото: Thaier Al-Sudani / Reuters
，详情可参考体育直播
Table of contents
Greater Than (2): Everything in this space must be greater than 2. The answer is 4-4, placed vertically.
Follow topics & set alerts with myFT